Catching AxSpA Early: Closing the Diagnostic Gap 

Early Peripheral SpA: Is it okay to stop treatment sometimes? 

Difficult to Manage axSpA 

Tofacitinib in AxSpA in Developing Countries 

Late-Breaking Trials in axSpA and PsA 

Durability and Safety of Bimekizumab 

Biologics Improve Sexual Function in axSpA 

Multidimensional Pain inventory in Axial SpA 

Spondyloarthritis: The CLASSIC Study 

Change it or Keep it? TNF in Axial SpA 

"Leftover Pain in Inflammatory Arthritis" 

B Cell Depletion: Check the Lymph Node 

"Next Generation T-Cell Engager: The Future" 

Off the Shelf: CAR-T 

Combining CAR-T with CAR-Treg All in One 

CAR-T Therapy: Where is it Heading? 

Safety of CAR-T 

New Paradigms in RA Treatment 

Perspectives on CAR T Therapy 

Wired for Success: Vagal Nerve Therapy in RA 

RA: Does upfront TNFi save heartache? 

New Paradigms in RA Treatment 

SLGT-2 and GLP-1 in RA: More than Weight Loss 

ACR2025 Day 1 RECAP 

Cellular Biomarkers of Rheumatoid Arthritis 

Day 2 Recap: ACR Convergence 2025 Highlights

STOP RA Cellular & Serologic Predictors 

Rheumatoid Arthritis: Inject the Steroids 

Is Low Disease Activity Low Enough? 

Catching PsA before it Starts 

Day 2 Recap: ACR Convergence 2025 Highlights 

PsA and Brain Fog 

GLP-1 Receptor Agonists in PsA: Mortality and MACE 

PsA Predictors 

When the Back Hurts: uncovering BASDAI drivers in PsA

The Upper Hand in PsA? Not the Dominant One

Diagnostic Delays in PsA: A Radiographic Perspective 

Late-Breaking Trials in axSpA and PsA 

New Approaches to Therapy in PsA 

Psoriatic Arthritis Imaging 

Specialized Biomarkers in PsA 

PsA: Impact of Sex 

GLP-1 and SGLT-2: Treatments Too Good to Ignore?